137
Views
4
CrossRef citations to date
0
Altmetric
Review

Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis

, &
Pages 1221-1228 | Received 29 Jul 2016, Accepted 07 Oct 2016, Published online: 20 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maria Gabriella Matera, Paola Rogliani, Josuel Ora & Mario Cazzola. (2018) Current pharmacotherapeutic options for pediatric lower respiratory tract infections with a focus on antimicrobial agents. Expert Opinion on Pharmacotherapy 19:18, pages 2043-2053.
Read now
Kristin M. Hudock & John Paul Clancy. (2017) An update on new and emerging therapies for cystic fibrosis. Expert Opinion on Emerging Drugs 22:4, pages 331-346.
Read now

Articles from other publishers (2)

Andre Schultz, Julie A. Marsh, Benjamin R. Saville, Richard Norman, Peter G. Middleton, Hugh W. Greville, Matthew I. Bellgard, Scott M. Berry & Tom Snelling. (2019) Trial Refresh: A Case for an Adaptive Platform Trial for Pulmonary Exacerbations of Cystic Fibrosis. Frontiers in Pharmacology 10.
Crossref
L. Keith Scott & Robert Toner. (2017) Clinically Promising Biomarkers in Cystic Fibrosis Pulmonary Exacerbations. Lung 195:4, pages 397-401.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.